LONDON, May 20 (Reuters) – British drugmaker AstraZeneca said that there could be no further negotiation with U.S. suitor Pfizer on the value of a takeover proposal, in a statement which it said it issued to clarify the situation under UK takeover rules.
Source: Financials
